Imidazo [1,2-B] pyridazine derivatives for the treatment of C-Met tyrosine kinase mediated disease

Details for Australian Patent Application No. 2009218459 (hide)

Owner Novartis AG

Inventors Furet, Pascal; Stauffer, Frederic; Spanka, Carsten; Stang, Melanie; McCarthy, Clive; Schoepfer, Joseph

Agent Davies Collison Cave

Pub. Number AU-A-2009218459

PCT Pub. Number WO2009/106577

Priority 08152068.6 28.02.08 EP

Filing date 26 February 2009

Wipo publication date 3 September 2009

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/5025 (2006.01) - ortho- or peri-condensed with heterocyclic ring systems

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

26 August 2010 PCT application entered the National Phase

  PCT publication WO2009/106577 Priority application(s): WO2009/106577

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009218460-Use of SIP1 as determinant of breast cancer stemness

2009218457-Lipases with high specificity towards short chain fatty acids and uses thereof